Pain relief study halted: did d-cycloserine fail for back pain?
NCT ID NCT03535688
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether D-cycloserine, a drug that affects brain signaling, could reduce pain in people with chronic low back pain that had not responded to other treatments. About 200 adults with at least 6 months of back pain and an average pain score of 4 or higher (on a 0–10 scale) were enrolled. The study was terminated early, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOW BACK PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Northwestern University Feinberg School of Medicine
Chicago, Illinois, 60611, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Electric pulses on the wrist may tame colonoscopy pain
- Can a smartphone app hypnotize away back pain?
- Virtual reality may distract patients from pain and fear during anesthesia
- Can a mind-body combo ease chronic back pain and sleeplessness?
- Water workouts could be the key to back pain relief